Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,778Revenue $M4.1Net Margin (%)-1,122.4Z-Score80.2
Enterprise Value $M1,544EPS $-0.7Operating Margin %-1,128.4F-Score4
P/E(ttm))0Cash Flow Per Share $-0.6Pre-tax Margin (%)-1,122.4Higher ROA y-yY
Price/Book7.410-y EBITDA Growth Rate %2.8Quick Ratio24.3Cash flow > EarningsY
Price/Sales05-y EBITDA Growth Rate %32.7Current Ratio24.3Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-31.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-34.4Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M82.8ROI % (ttm)-45.4Gross Margin Increase y-yN

Gurus Latest Trades with EXAS

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
EXASPRIMECAP Management 2014-06-30 Buy 0.05%$11.17 - $17.27
($13.72)
$ 22.1962%New holding, 2491300 sh.2,491,300
EXASGeorge Soros 2014-06-30 Sold Out -0.03%$11.17 - $17.27
($13.72)
$ 22.1962%Sold Out0
EXASGeorge Soros 2014-03-31 Buy 0.03%$11.75 - $14.82
($13.45)
$ 22.1965%New holding, 200000 sh.200,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

EXAS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
EXAS PRIMECAP Management 2014-06-302,491,3003.010.05New Buy
EXAS George Soros 2014-06-30000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


EXAS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Conroy Kevin TPresident and CEO 2014-07-25Sell11,336$15.9933.08view
ARORA MANEESHCOO 2014-07-25Sell9,291$15.9933.08view
LIDGARD GRAHAM PETERSr. VP, Chief Science Officer 2014-07-25Sell11,081$15.9933.08view
Megan William J.SVP, Finance & PFO 2014-05-05Buy10,000$11.7980.49view
LIDGARD GRAHAM PETERSr. VP, Chief Science Officer 2014-02-24Sell3,160$14.0751.24view
ARORA MANEESHCOO 2014-02-24Sell2,662$14.0751.24view
Conroy Kevin TPresident and CEO 2014-02-24Sell8,708$14.0751.24view
ARORA MANEESHCOO 2014-01-02Sell8,627$11.9677.93view
LIDGARD GRAHAM PETERSr. VP, Chief Science Officer 2014-01-02Sell10,288$11.9677.93view
Conroy Kevin TPresident and CEO 2014-01-02Sell26,379$11.9677.93view

Press Releases about EXAS :

    Quarterly/Annual Reports about EXAS:

    News about exas:

    Articles On GuruFocus.com
    Meridian Funds Comments on Exact Sciences Corp Jun 20 2014 
    comment on EXAS May 12 2013 
    comment on EXAS May 12 2013 
    comment on EXAS May 12 2013 
    Weekly CEO Buys Highlight: BFS, FL, BGC, AMCF, and EXAS Nov 28 2010 
    EXACT Sciences Corp. (EXAS) CEO Kevin T Conroy buys 6,000 Shares Nov 23 2010 
    EXACT Sciences Corp. (EXAS) CFO Maneesh Arora buys 2,500 Shares Aug 20 2010 
    cooldecency99 note on EXAS May 01 2010 
    Weekly CFO Buys Highlight: Heska Corp., Apollo Investment Corp., EXACT Sciences Corp., Innospec Inc. Feb 28 2010 
    Exact Sciences Reports Second-Quarter 2009 Financial Results Aug 12 2009 


    More From Other Websites
    Nasdaq stocks posting largest percentage increases Aug 27 2014
    Exact Sciences draws call buying Aug 25 2014
    Exact Sciences Announces Mayo Clinic as First Healthcare System to Offer Cologuard® Aug 25 2014
    Exact Sciences Announces Mayo Clinic as First Healthcare System to Offer Cologuard® Aug 25 2014
    Exact Sciences Corporation (EXAS) Jumps: Stock Rises 6.4% Aug 21 2014
    [video] Breakout stocks: EEM, NKE, EXAS, GDX Aug 19 2014
    Biotech Stock Mailbag: Exact Sciences, Galena, Amgen Aug 15 2014
    US STOCKS-Wall St falls modestly with Ukraine in focus Aug 12 2014
    US STOCKS-Wall St falls modestly with Ukraine in focus Aug 12 2014
    US STOCKS-Wall St dips with Ukraine in focus Aug 12 2014
    US STOCKS-Wall St dips with Ukraine in focus Aug 12 2014
    Why Exact Sciences (EXAS) Stock Is Gaining Today Aug 12 2014
    [video] Exact Sciences CEO On FDA Approval of its Colon Cancer Screening Test Aug 12 2014
    US STOCKS-Wall St flat amid Ukraine uncertainty Aug 12 2014
    US STOCKS-Wall St flat amid Ukraine uncertainty Aug 12 2014
    FDA Approves Exact Sciences' Cologuard®; First and Only Stool DNA Noninvasive Colorectal Cancer... Aug 12 2014
    [video] Cramer's stocks to watch: Intercept & Exact Sciences Aug 12 2014
    [video] FDA approves non-invasive colon cancer screening test Aug 12 2014
    FDA approves DNA test for colon cancer Aug 12 2014
    FDA Approves Exact Sciences' Cologuard®; First and Only Stool DNA Noninvasive Colorectal Cancer... Aug 12 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK